KMT2A and leukemia: The histone lysine demethylase KDM2A was described to be an opposing regulator of ASH1L by specifically demethylating H3K36me2, which leads to the dissociation of KMT2A/PS1P1 and the decreased description of KMT2A target leukemia genes.